How can we solve for VACCINE?

Post to Vaccine

Priority Topics
These are the priority topics that are related to VACCINE, according to SolveCasters.
More Sort Classification Topic Created
2 Follow WORK FROM HOME 2 months ago
7 Priority ANTIBODY 8 months ago
7 Priority INEQUALITY 6 months ago
2 Follow PANDEMIC 1 month ago
7 Priority IMMUNE RESPONSE 8 months ago
7 Priority HOSPITAL 7 months ago
0 Low Priority PREVENTING AND TREATING COVID-19 9 months ago
7 Priority LOGISTICS 6 months ago
7 Priority CORONAVIRUS 7 months ago
7 Priority PFIZER 5 months ago
7 Priority GUILT (EMOTION) 6 months ago
7 Priority VIRUS 8 months ago
2 Follow INFECTIOUS DISEASE 1 month ago
2 Follow ILLINOIS 7 months ago
2 Follow COVID-19 10 months ago
7 Priority ALTRUISM 6 months ago
7 Priority CLINICAL TRIAL 8 months ago
Note: Information may have been automatically generated.
We all view the world from different perspectives. Perspectives can represent a person, a group of people, a data source and more. Choose an item below to understand what topics are important to VACCINE from the point of view of that perspective.
Name Description
SolveCasters (ME) Curated by SolveCast podcasters and editors.
Worldwide Media Automatically generated from scanning world media.
Bill Gates Bill Gates curated from media.
Automated media search by SolveCasters Auutomated custom media search, focusing on United States with focus on results that would yield innovation.
Latest Links
Latest aggregated links.
Posts provide more information and keep you up to date about each topic. The following posts are by SolveCasters.

A preliminary report from the Clalit Research Institute compared the infection data of 200 000 people aged 60 and over who were not vaccinated with the infection data of 200 000 people of the same age group who received one vaccine dose and were monitored for at least 11 days from the date of vaccination. On day 14 there was a “significant decrease of about 33% in the rate of positive tests for the coronavirus” among those who had been vaccinated. This decrease remained the same between days 15 and 17.

The report has raised concerns, as published results have suggested that the efficacy of the Pfizer vaccine was 52.4% between the first and second dose (spaced 21 days apart), and data assessed by Public Health England indicated it could be as much as 89% protective from day 15 to 21.

The Clalit Research Institute stressed, however, that its results included only people aged 60 and over—whereas Pfizer trials also included younger people—and that the findings have not yet been peer reviewed. Additionally, the Clalit study identified those infected according to laboratory tests of those who chose to be tested, while Pfizer’s studies only referred to the appearance of symptomatic disease.

“Don’t feel guilty. Go get vaccinated. How you’re going to help the people that are now eligible is by getting vaccinated and limiting an exposure point for them. Right, so it’s going to take us time to get to everyone. We’re going to move into our older populations in the coming phases as we move forward,” said Public Health Director Frank Kruppa.

Vaccinated individuals comparing themselves to others is often empathetic and compassionate, but ultimately unproductive, said Jessica Stern, a clinical psychologist and assistant professor at NYU Langone Health.

“Individuals don’t necessarily need to concern themselves with those systems to decide if they are deserving,” she said. “Responding to Covid is a communal team effort. As much as we have to work as a team to adopt safety precautions, it’s also our responsibility to get the vaccine.”